Generic Name |
Pembrolizumab + Epacadostat | |
---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
Merck + Incyte | |
Drug Type |
Immunotherapy | |
Delivery |
Intravenous + Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
Immune system | |
Strategy |
Immune checkpoint inhibition | |
Drug Category |
PD-1 + IDO1 inhibitor |
Links |
|
Trials of this drug |
|
|
Epacadostat and Pembrolizumab in Patients With GIST Epacadostat and Pembrolizumab in Patients With GIST |
Trial results |